rs137854585
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000397.4(CYBB):c.1244C>A(p.Pro415His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/19 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P415L) has been classified as Pathogenic.
Frequency
Consequence
NM_000397.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYBB | NM_000397.4 | c.1244C>A | p.Pro415His | missense_variant | 10/13 | ENST00000378588.5 | |
CYBB | XM_047441855.1 | c.938C>A | p.Pro313His | missense_variant | 9/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYBB | ENST00000378588.5 | c.1244C>A | p.Pro415His | missense_variant | 10/13 | 1 | NM_000397.4 | P1 | |
CYBB | ENST00000696171.1 | c.1148C>A | p.Pro383His | missense_variant | 9/12 | ||||
CYBB | ENST00000696170.1 | c.*753C>A | 3_prime_UTR_variant, NMD_transcript_variant | 9/12 |
Frequencies
GnomAD3 genomes ? Cov.: 24
GnomAD4 exome Cov.: 30
GnomAD4 genome ? Cov.: 24
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2019 | - - |
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Granulomatous disease, chronic, X-linked, variant Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 19, 2019 | - - |
Granulomatous disease, chronic, X-linked Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Mar 03, 2020 | This variant has been observed in individual(s) with chronic granulomatous disease (PMID: 2556453, 11162142). ClinVar contains an entry for this variant (Variation ID: 10920). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Pro415 amino acid residue in CYBB. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11162142, Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has been reported to affect CYBB protein function (PMID: 20724480). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with histidine at codon 415 of the CYBB protein (p.Pro415His). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and histidine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at